查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855778

2025年全球体外诊断（IVD）人工智慧（AI）市场报告

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，体外诊断（IVD）领域的人工智慧（AI）市场发展迅猛，预计将从2024年的25.7亿美元成长到2025年的30.4亿美元，复合年增长率（CAGR）高达18.5%。推动这一增长的主要因素包括：熟练的医疗保健专业人员和放射科医生短缺、政府和监管机构对基于人工智能的诊断技术的支持力度不断加大、人工智能在基因组和分子诊断领域的应用日益广泛、临床医生对人工智能诊断准确性的认识不断提高，以及云端基础的人工智能诊断解决方案的日益广泛。

预计未来几年，体外诊断（IVD）领域的人工智慧（AI）市场将快速成长，到2029年市场规模将达到59.4亿美元，复合年增长率（CAGR）为18.2%。预测期内的成长预计将受到以下因素的驱动：对快速准确诊断结果的需求不断增长、慢性病和感染疾病的流行、对个人化和精准医疗日益增长的需求、对疾病早期检测和预防的重视，以及由于电子健康记录的广泛应用而推动的医疗保健数位化进程。预测期内的主要趋势包括：深度学习在病理学和诊断成像领域的进步、全自动高通量分析仪的创新、自然语言处理在诊断报告中的应用、人工智慧远距离诊断平台的开发，以及人工智慧与穿戴式装置和照护现场设备的整合。

体外诊断 (IVD) 中的人工智慧 (AI) 是指应用先进的演算法来分析从血液、组织、尿液和其他样本的实验室测试中获得的医学数据，从而实现更快、更准确、更数据主导的测试结果解释，支持更早的疾病检测、个性化治疗决策和提高诊断效率。

体外诊断中人工智慧的主要组成部分包括软体、硬体和服务。软体由程式和资料构成，使电脑能够执行特定任务。它利用机器学习、自然语言处理、电脑视觉、机器人流程自动化和深度学习等技术，并可以以云端基础、本地或混合模式部署。应用领域包括诊断影像、实验室检测、病理学、基因组学和个人化医疗。主要终端使用者包括医院和诊所、诊断实验室、研究机构、製药公司和医疗设备製造商。

美国关税的快速上涨以及持续到2025年春季的贸易摩擦，对医疗设备行业产生了重大影响，尤其是进口诊断成像设备部件、手术用不銹钢和塑胶耗材。医院和诊所抵制价格上涨，挤压了製造商的净利率。监管障碍加剧了这个问题，因为与关税相关的供应商变更通常需要重新认证设备，从而延缓了产品上市时间。企业正透过关键零件的双重采购、扩大国内同质化产品的生产以及加速研发经济高效材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）最新发布的系列研究报告之一，涵盖体外诊断人工智慧（AI）市场统计数据，包括全球市场规模、区域份额、体外诊断人工智慧（AI）市场份额的竞争对手、体外诊断人工智慧（AI）市场的详细细分、市场趋势和商业机会，以及您在体外诊断人工智慧（AI）行业取得成功所需的数据。本体外诊断人工智慧（AI）市场研究报告透过对产业现状和未来发展趋势的详细分析，为您提供所需的全面观点。

个人化医疗需求的不断增长预计将推动人工智慧 (AI) 在体外诊断 (IVD) 领域的市场扩张。个人化医疗是指根据个人的基因谱、生活方式和环境，量身订做预防、诊断和治疗方案。个人化医疗的日益普及主要归功于基因组数据和定序技术的进步，这些技术能够实现更精准、更有效、更具针对性的治疗。人工智慧在体外诊断领域发挥关键作用，它透过分析复杂的诊断数据，识别每位患者特有的疾病模式，并协助医疗服务提供者做出及时且准确的治疗决策。例如，根据个人化医疗联盟 (Personalized Medicine Coalition) 2024 年 2 月发布的报告，美国食品药物管理局 (FDA) 在 2023 年核准了16 种针对罕见疾病的新型个人化疗法，较 2022 年的 6 种显着增加。这些疗法包括 7 种癌症药物和 3 种其他疾病药物。因此，对个人化医疗日益增长的需求正在推动人工智慧在体外诊断领域的发展。

体外诊断人工智慧 (IVD AI) 市场的企业正致力于开发先进的解决方案，例如获得 CE-IVDR 认证的透明人工智慧平台，以提高诊断准确性、简化工作流程并支援个人化患者照护。获得 CE-IVDR 认证的透明人工智慧平台是一种符合欧盟监管标准并提供清晰、审核决策的人工智慧系统。 2025 年 5 月，英国诊断检测公司 Diagnostics.ai 推出了 PCR.AI，这是一款旨在加速和改进 PCR 诊断的先进解决方案。该平台能够自动解读即时PCR结果，准确率超过 99.9%，并透过清晰地展示每个结果的推导过程来提高透明度。此功能确保了符合监管要求，并增强了临床信心。此外，它还显着提高了实验室效率，减少了错误，并支持分子诊断的无缝监管合规。

2025年4月，总部位于法国的生物梅里埃公司（bioMerieux SA）与加拿大人工智慧研究机构Mila合作，旨在推动人工智慧驱动的诊断和抗生素抗药性检测领域的研究与创新。该合作旨在开发尖端人工智慧解决方案，以提高体外诊断的准确性和效率，特别着重于提升抗生素抗药性检测能力。 Mila以其在机器学习和人工智慧研究领域的开创性工作而闻名。

体外诊断（IVD）人工智慧（AI）市场包括提供预测分析服务、远距离诊断和病理服务、工作流程自动化和优化服务、数据标註以及临床决策支援服务等服务的营业单位所获得的收入。此市场价值还包括服务供应商销售的或包含在其服务产品中的相关产品的价值。体外诊断（IVD）人工智慧（AI）市场还包括自动化检测设备、人工智慧数位病理扫描仪和液态切片诊断试剂套件的销售额。这指的是产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向终端客户销售的产品价值。该市场的产品价值还包括产品製造商销售的相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球人工智慧（AI）在体外诊断（IVD）领域的应用：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球体外诊断（IVD）人工智慧（AI）市场：增长率分析
  • 全球体外诊断（IVD）人工智慧（AI）市场表现：规模与成长，2019-2024年
  • 全球体外诊断（IVD）人工智慧（AI）市场预测：规模与成长，2024-2029年，2034年预测
  • 全球体外诊断（IVD）人工智慧（AI）市场：潜在市场规模（TAM）

第六章 市场细分

  • 全球体外诊断（IVD）人工智慧（AI）市场：按组件、性能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 软体
  • 硬体
  • 服务
  • 全球体外诊断（IVD）人工智慧（AI）市场：依技术、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 机器学习
  • 自然语言处理
  • 电脑视觉
  • 机器人和流程自动化
  • 深度学习
  • 全球体外诊断（IVD）人工智慧（AI）市场：依部署模式、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 云端基础的
  • 本地部署
  • 杂交种
  • 全球体外诊断（IVD）人工智慧（AI）市场：按应用、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 影像诊断
  • 实验室检查
  • 病理
  • 基因组学
  • 个人化医疗
  • 全球体外诊断（IVD）人工智慧（AI）市场依最终用户、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 医院和诊所
  • 诊断实验室
  • 研究所
  • 製药公司
  • 医疗设备製造商
  • 全球体外诊断（IVD）人工智慧（AI）市场－按软体、类型、实际值和预测值细分，2019-2024年、2024-2029年预测值、2034年预测值
  • 诊断演算法
  • 数据分析平台
  • 决策支援系统
  • 全球体外诊断（IVD）人工智慧（AI）市场－按硬体、类型、实际值和预测值细分，2019-2024年、2024-2029年预测值、2034年预测值
  • 实验室设备
  • 影像设备
  • 即时检测设备
  • 全球体外诊断（IVD）人工智慧（AI）市场－按服务、类型、实际值和预测值细分，2019-2024年、2024-2029年预测值、2034年预测值
  • 咨询与实施
  • 维护和支援
  • 培训和教育

第七章 区域和国家分析

  • 全球体外诊断（IVD）人工智慧（AI）市场按地区划分、绩效及预测（2019-2024年、2024-2029年预测、2034年预测）
  • 全球体外诊断（IVD）人工智慧（AI）市场按国家划分，绩效及预测（2019-2024年、2024-2029年预测、2034年预测）。

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 体外诊断（IVD）中的人工智慧（AI）：竞争格局
  • 体外诊断（IVD）市场中的人工智慧（AI）：公司概况
    • Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Illumina Inc.
  • Hologic Inc.
  • Sysmex Corporation
  • QIAGEN NV
  • Tempus Labs Inc.
  • BillionToOne Inc.
  • PathAI Inc.
  • Proscia Inc.
  • Indica Labs Inc.
  • Visiopharm A/S
  • aetherAI Co. Ltd.
  • Ibex Medical Analytics Ltd.
  • Mindpeak GmbH
  • OncoHost Ltd.
  • Qritive

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年体外诊断（IVD）人工智慧（AI）市场：提供新机会的国家
  • 2029年体外诊断（IVD）人工智慧（AI）市场：提供新机会的细分领域
  • 2029年体外诊断（IVD）人工智慧（AI）市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38426

Artificial intelligence (AI) in in vitro diagnostics (IVD) refers to the application of advanced algorithms to analyze medical data obtained from laboratory tests on samples such as blood, tissue, or urine. It enables faster, more accurate, and data-driven interpretation of test results, supporting early disease detection, personalized treatment decisions, and enhanced diagnostic efficiency.

The primary components of AI in in vitro diagnostics include software, hardware, and services. Software consists of programs and data that instruct a computer to perform specific tasks. It leverages technologies such as machine learning, natural language processing, computer vision, robotic process automation, and deep learning, and can be deployed through cloud-based, on-premise, or hybrid methods. Applications include diagnostic imaging, laboratory testing, pathology, genomics, and personalized medicine. Primary end users include hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical companies, and medical device manufacturers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The artificial intelligence (AI) in in vitro diagnostics market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in in vitro diagnostics market statistics, including artificial intelligence (AI) in the in vitro diagnostics industry's global market size, regional shares, competitors with an artificial intelligence (AI) in the in vitro diagnostics market share, detailed artificial intelligence (AI) in in vitro diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in the in vitro diagnostics industry. This artificial intelligence (AI) in vitro diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market size has grown rapidly in recent years. It will grow from $2.57 billion in 2024 to $3.04 billion in 2025 at a compound annual growth rate (CAGR) of 18.5%. Growth in the historic period was driven by a shortage of skilled healthcare professionals and radiologists, increasing government and regulatory support for AI-based diagnostics, growing application of AI in genomic and molecular diagnostics, rising awareness among clinicians of AI-enabled diagnostic accuracy, and greater availability of cloud-based AI diagnostic solutions.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market size is expected to see rapid growth in the next few years. It will grow to $5.94 billion in 2029 at a compound annual growth rate (CAGR) of 18.2%. Growth in the forecast period is expected to result from increasing demand for rapid and accurate diagnostic results, higher prevalence of chronic and infectious diseases, growing need for personalized and precision medicine approaches, stronger focus on early disease detection and prevention, and greater healthcare digitization with widespread adoption of electronic health records. Primary trends anticipated for the forecast period include advancements in deep learning for pathology and imaging, innovations in fully automated high-throughput analyzers, integration of natural language processing in diagnostic reporting, development of AI-enabled remote diagnostic platforms, and integration of AI with wearable and point-of-care devices.

The growing demand for personalized medicine is expected to drive the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market. Personalized medicine involves tailoring prevention, diagnosis, and treatment based on an individual's genetic profile, lifestyle, and environment. The increasing adoption of personalized medicine is largely fueled by advancements in genomic data and sequencing technologies, which allow for more precise, effective, and targeted treatments. AI in IVD plays a vital role by analyzing complex diagnostic data to identify disease patterns specific to each patient, helping healthcare providers make timely and accurate treatment decisions. For example, the Personalized Medicine Coalition reported that in February 2024, the FDA approved 16 new personalized treatments for rare diseases in 2023, a significant increase from six in 2022. This includes seven cancer drugs and three treatments for other conditions. The rising demand for personalized medicine is thus driving the growth of AI in IVD.

Companies in the AI in IVD market are focused on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms, to improve diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform is an AI system that meets EU regulatory standards, providing clear, auditable decision-making. In May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, an advanced solution designed to speed up and improve PCR diagnostics. This platform automates real-time PCR result interpretation with over 99.9% accuracy, offering transparency by clearly displaying how each result is derived. This feature ensures regulatory compliance and enhances clinical trust. It also significantly boosts laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.

In April 2025, bioMerieux SA, a France-based company specializing in AI for IVD, partnered with Mila, a Canadian AI research institute, to advance research and innovation in AI-driven diagnostics and antibiotic resistance detection. The collaboration aims to create cutting-edge AI solutions that enhance the accuracy and efficiency of IVD tools, with a particular focus on improving the detection of antibiotic resistance. Mila is renowned for its pioneering work in machine learning and AI research.

Major players in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, and Aiforia Technologies Oyj.

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) in in vitro diagnostics (IVD) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI) in in vitro diagnostics (IVD) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market includes revenues earned by entities by providing services such as predictive analytics services, remote diagnostic and telepathology services, workflow automation, optimization services, data annotation, and clinical decision support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in in vitro diagnostics (IVD) market also includes sales of automated laboratory instruments, artificial intelligence-enabled digital pathology scanners, and liquid biopsy diagnostic kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai) in in vitro diagnostics (ivd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) in in vitro diagnostics (ivd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) in in vitro diagnostics (ivd) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Technology: Machine Learning; Natural Language Processing; Computer Vision; Robotics Process Automation; Deep Learning
  • 3) By Deployment Model: Cloud-Based; On-Premise; Hybrid
  • 4) By Application: Diagnostic Imaging; Laboratory Testing; Pathology; Genomics; Personalized Medicine
  • 5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Pharmaceutical Companies; Medical Device Manufacturers
  • Subsegments:
  • 1) By Software: Diagnostic Algorithms; Data Analytics Platforms; Decision Support Systems
  • 2) By Hardware: Laboratory Instruments; Imaging Devices; Point-Of-Care Devices
  • 3) By Services: Consulting And Implementation; Maintenance And Support; Training And Education
  • Companies Mentioned: Roche Diagnostics GmbH; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Illumina Inc.; Hologic Inc.; Sysmex Corporation; QIAGEN N.V.; Tempus Labs Inc.; BillionToOne Inc.; PathAI Inc.; Proscia Inc.; Indica Labs Inc.; Visiopharm A/S; aetherAI Co. Ltd.; Ibex Medical Analytics Ltd.; Mindpeak GmbH; OncoHost Ltd.; Qritive; Aiforia Technologies Oyj.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Characteristics

3. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Trends And Strategies

4. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Total Addressable Market (TAM)

6. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Segmentation

  • 6.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Hardware
  • Services
  • 6.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Machine Learning
  • Natural Language Processing
  • Computer Vision
  • Robotics Process Automation
  • Deep Learning
  • 6.3. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cloud-Based
  • On-Premise
  • Hybrid
  • 6.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Imaging
  • Laboratory Testing
  • Pathology
  • Genomics
  • Personalized Medicine
  • 6.5. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical Companies
  • Medical Device Manufacturers
  • 6.6. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Algorithms
  • Data Analytics Platforms
  • Decision Support Systems
  • 6.7. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Instruments
  • Imaging Devices
  • Point-Of-Care Devices
  • 6.8. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting And Implementation
  • Maintenance And Support
  • Training And Education

7. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 8.1. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 9.1. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 9.2. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 10.1. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 11.1. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 11.2. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 12.1. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 13.1. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 14.1. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 14.2. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 15.1. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 15.2. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 16.1. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 17.1. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 18.1. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 19.1. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 20.1. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 21.1. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 21.2. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 22.1. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 23.1. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 23.2. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 24.1. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 24.2. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 25.1. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 25.2. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 26.1. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 26.2. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 27.1. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 28.1. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 28.2. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 29.1. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 29.2. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Landscape
  • 30.2. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Company Profiles
    • 30.2.1. Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Hologic Inc.
  • 31.3. Sysmex Corporation
  • 31.4. QIAGEN N.V.
  • 31.5. Tempus Labs Inc.
  • 31.6. BillionToOne Inc.
  • 31.7. PathAI Inc.
  • 31.8. Proscia Inc.
  • 31.9. Indica Labs Inc.
  • 31.10. Visiopharm A/S
  • 31.11. aetherAI Co. Ltd.
  • 31.12. Ibex Medical Analytics Ltd.
  • 31.13. Mindpeak GmbH
  • 31.14. OncoHost Ltd.
  • 31.15. Qritive

32. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

34. Recent Developments In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

35. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer